MEMBRANE-BASED AFFINITY TECHNOLOGY FOR COMMERCIAL SCALE PURIFICATIONS
MEMBRANE-BASED AFFINITY TECHNOLOGY FOR COMMERCIAL SCALE PURIFICATIONS
复制标题
DOI：
10.1038/nbt0788-779
复制
发表时间：
1988-07-01
期刊：
影响因子：
--
通讯作者：
ZALE, SE
中科院分区：
文献类型：
--
作者：
BRANDT, S;GOFFE, RA;ZALE, SE
将产品和技术商业化需要认识到这种努力的复杂性和多层次性质——从通过专利保护建立专有地位到扩大生产；从净化产品到食品和药物管理局（FDA）的标准，再到建立适当的营销和分销渠道。而且，既然产品的可专利性本身就是一个问题”，公司正在探索保护其市场地位的替代方法。越来越多的焦点转向开发专有的分离技术。高效的分离也将有利于扩大生产规模，以满足消费者的需求。
Commercializing products and technologies requires an appreciation of the complex, multi-level nature of such an effort-from establishing a proprietary position via patent protection to scaling-up production; from purifying that product to Food and Drug Administration (FDA) standards to establishing the proper marketing and distribution channels. And, now that product patentability itself is at issue", companies are ex-ploring alternate means of safeguarding their market positions. Increasingly, the focus is shifting to developing proprietary separation technologies. And efficient separations will also benefit scaling-up produc-tion to meet consumer demands.